AdityaBagrodiaMD

PubMed

• Editorial Comment.
  Kshitij Pandit, Margaret Meagher, Aditya Bagrodia
  The Journal of Urology. 2025-01-01
• Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
  Kshitij Pandit, Paul Riviere, Kylie Morgan, Tyler Nelson, Margaret Meagher
  The Journal of Urology. 2025-01-01
• Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
  Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky
  BJU International. 2024-12-11

Journal Articles

• Clonal Relatedness and Mutational Differences Between Upper Tract and Bladder Urothelial Carcinoma  
  Aditya Bagrodia, Paari Murugan, Clinical Cancer Research
• Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?  
  Krabbe LM, Bagrodia A, Westerman ME, Gayed BA, Haddad AQ, Sagalowsky AI, et al., World J Urol, 1/1/2016
• Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma  
  Li Q, Bagrodia A, Cha EK, Coleman JA, Current urology reports, 1/1/2016
• Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer  
  Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, et al., Nat Genet, 1/1/2016
• Genomic characterization of response to chemoradiation in urothelial bladder cancer  
  Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, et al, Cancer, 1/1/2016
• Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study  
  Passoni NM, Shariat SF, Bagrodia A, Francis F, Rachakonda V, Xylinas E, et al., Bl Cancer, 1/1/2016
• Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned  
  Gayed BA, Youssef R, Darwish O, Kapur P, Bagrodia A, Brugarolas J, et al., BMC Urol., 1/1/2016
• Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma  
  Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA, et al., J Urol., 1/1/2016
• Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract  
  Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, et al., J Urol, 1/1/2015
• Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma  
  Singla N, Gayed BA, Bagrodia A, Krabbe LM, Palazzi KL, Mirheydar H, et al., Urol Oncol, 1/1/2015
• Genomic Characterization of Upper Tract Urothelial Carcinoma  
  Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH,Bagrodia A, et al., Eur Urol, 1/1/2015
• Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary results  
  Gayed BA, Bagrodia A, Gaitonde M, Krabbe LM, Meissner M, Kapur P, et al, Urol Oncol, 1/1/2015
• Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy  
  Shariat SF, Passoni N, Bagrodia A, Rachakonda V, Xylinas E, Robinson B, et al., BJU Int, 1/1/2014
• Diagnosis and management of upper tract urothelial carcinoma  
  Krabbe LM, Bagrodia A, Westerman ME, Margulis V, Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1/1/2014
• Surgical management of renal cell carcinoma  
  Krabbe LM, Bagrodia A, Margulis V, Wood CG, Seminars in interventional radiology, 1/1/2014
• Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses  
  Bagrodia A, Harrow B, Liu ZW, Olweny EO, Faddegon S, Yin G, et al., Urol Oncol., 1/1/2014
• Impact of renal surgery for cortical neoplasms on lipid metabolism  
  Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, et al., BJU Int, 1/1/2014
• Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival  
  Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, et al., Urol Oncol, 1/1/2014
• Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma  
  Gayed BA, Youssef RF, Bagrodia A, Darwish OM, Kapur P, Sagalowsky A, et al., BJU Int, 1/1/2014
• Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources  
  Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, et al., J Urol, 1/1/2014
• Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a revie...  
  Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, et al., Urol Oncol, 1/1/2014
• Dysregulation of beta-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma  
  Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Darwish OM, Haddad AQ, et al., J Urol, 1/1/2014
• Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?  
  Krabbe LM, Lotan Y, Bagrodia A, Gayed BA, Darwish OM, Youssef RF, et al., J Urol, 1/1/2014
• Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract  
  Chung PH, Krabbe LM, Darwish OM, Westerman ME, Bagrodia A, Gayed BA, et al., Urol Oncol, 1/1/2014
• Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma  
  Krabbe LM, Bagrodia A, Lotan Y, Gayed BA, Darwish OM, Youssef RF, et al., J Urol, 1/1/2014
• Join now to see all